Markets:

Overview

News

Currencies

International

Treasuries

Direxion Daily S&P Biotech Bear 3X Shares (NY:LABD)

26.79 -1.43 (-5.07%)

Official Closing Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Direxion Daily S&P Biotech Bear 3X Shares

EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks ↗

August 30, 2024

Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.

Via Benzinga

5 Inverse ETFs That Gained More Than 20% in April ↗

May 01, 2024

The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market’s worst month of 2024.

Via Talk Markets

Topics ETFs

5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3 ↗

October 02, 2023

The third quarter proved to be highly volatile and uncertain for the U.S. stock market. This has resulted in huge demand for leveraged or inverse-leveraged ETFs as these fetch outsized returns on quick...

Via Talk Markets

Topics ETFs

5 Inverse ETFs That Gained In Double Digits In August ↗

September 03, 2023

August was a dull month for Wall Street, with all three major indices finishing in the red. This resulted in huge demand for inverse or inverse-leveraged ETFs, as these often fetch outsized returns on...

Via Talk Markets

Topics ETFs

Inverse ETFs Soar as Market Turns Sour ↗

August 09, 2023

After an astounding rally, Wall Street has been caught in feeble trading in the past week, triggered by the U.S. credit rating downgrade and now bank downgrades.

Via Talk Markets

Want Diversified Upside in Biotechnology? Check out LABU

March 22, 2023

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.

Via MarketBeat

Topics ETFs Stocks

5 Best Inverse-Leveraged ETFs Of February ↗

March 01, 2023

For ETF investors bearish on equities for the near term, either of these products could make an interesting choice.

Via Talk Markets

Stocks See Worst Day in 2 Years: Inverse ETFs Shine ↗

May 19, 2022

Wall Street logged in its worst day since the early months of the pandemic due to rounds of disappointing earnings from some of the major retailers, underscoring that inflation is hurting corporate...

Via Talk Markets

5 Inverse ETFs Enjoying A Rally This Year ↗

April 19, 2022

Wall Street is caught in a vicious circle of trading this year triggered by inflationary pressures, Fed’s tightening policy and the war in Ukraine.

Via Talk Markets

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 07, 2021

Good morning, trader! We're beginning another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

5 Leveraged/Inverse ETFs Up More Than 15% in November ↗

December 02, 2021

Amid the volatility, leveraged and inverse-leveraged ETFs gained increased popularity as these fetched outsized returns on the quick market turns in a short span.

Via Talk Markets

7 Inverse ETFs Riding High on Nasdaq Sell-Off ↗

May 11, 2021

Here are seven inverse ETFs that benefited the most from the Nasdaq sell-off on the day.

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Direxion Daily S&P Biotech Bear 3X Shares (NY:LABD)

All News about Direxion Daily S&P Biotech Bear 3X Shares

Starting at $3.75/week.

Subscribe Today